Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$36.12 - $47.5 $2.36 Million - $3.11 Million
65,370 New
65,370 $2.62 Million
Q3 2021

Nov 12, 2021

SELL
$54.64 - $61.3 $327,075 - $366,941
-5,986 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$59.18 - $69.99 $354,251 - $418,960
5,986 New
5,986 $363,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.09B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.